1. Home
  2. CDNA vs BLMN Comparison

CDNA vs BLMN Comparison

Compare CDNA & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • BLMN
  • Stock Information
  • Founded
  • CDNA 1998
  • BLMN 1988
  • Country
  • CDNA United States
  • BLMN United States
  • Employees
  • CDNA N/A
  • BLMN N/A
  • Industry
  • CDNA Medical Specialities
  • BLMN Restaurants
  • Sector
  • CDNA Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • CDNA Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • CDNA 844.7M
  • BLMN 714.5M
  • IPO Year
  • CDNA 2014
  • BLMN 2012
  • Fundamental
  • Price
  • CDNA $16.99
  • BLMN $7.63
  • Analyst Decision
  • CDNA Buy
  • BLMN Hold
  • Analyst Count
  • CDNA 6
  • BLMN 11
  • Target Price
  • CDNA $30.33
  • BLMN $13.75
  • AVG Volume (30 Days)
  • CDNA 1.4M
  • BLMN 2.9M
  • Earning Date
  • CDNA 04-30-2025
  • BLMN 05-07-2025
  • Dividend Yield
  • CDNA N/A
  • BLMN 7.86%
  • EPS Growth
  • CDNA N/A
  • BLMN N/A
  • EPS
  • CDNA 1.07
  • BLMN N/A
  • Revenue
  • CDNA $346,421,000.00
  • BLMN $3,930,996,000.00
  • Revenue This Year
  • CDNA $13.38
  • BLMN $1.28
  • Revenue Next Year
  • CDNA $15.33
  • BLMN $1.67
  • P/E Ratio
  • CDNA $15.81
  • BLMN $8.44
  • Revenue Growth
  • CDNA 25.92
  • BLMN N/A
  • 52 Week Low
  • CDNA $12.90
  • BLMN $6.09
  • 52 Week High
  • CDNA $34.84
  • BLMN $22.34
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 49.78
  • BLMN 45.27
  • Support Level
  • CDNA $16.57
  • BLMN $7.62
  • Resistance Level
  • CDNA $18.02
  • BLMN $8.03
  • Average True Range (ATR)
  • CDNA 0.77
  • BLMN 0.43
  • MACD
  • CDNA 0.14
  • BLMN -0.07
  • Stochastic Oscillator
  • CDNA 59.45
  • BLMN 14.37

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: